Literature DB >> 19095069

Real-time MR imaging of adeno-associated viral vector delivery to the primate brain.

Massimo S Fiandaca1, Vanja Varenika, Jamie Eberling, Tracy McKnight, John Bringas, Phillip Pivirotto, Janine Beyer, Piotr Hadaczek, William Bowers, John Park, Howard Federoff, John Forsayeth, Krystof S Bankiewicz.   

Abstract

We are developing a method for real-time magnetic resonance imaging (MRI) visualization of convection-enhanced delivery (CED) of adeno-associated viral vectors (AAV) to the primate brain. By including gadolinium-loaded liposomes (GDL) with AAV, we can track the convective movement of viral particles by continuous monitoring of distribution of surrogate GDL. In order to validate this approach, we infused two AAV (AAV1-GFP and AAV2-hAADC) into three different regions of non-human primate brain (corona radiata, putamen, and thalamus). The procedure was tolerated well by all three animals in the study. The distribution of GFP determined by immunohistochemistry in both brain regions correlated closely with distribution of GDL determined by MRI. Co-distribution was weaker with AAV2-hAADC, although in vivo PET scanning with FMT for AADC activity correlated well with immunohistochemistry of AADC. Although this is a relatively small study, it appears that AAV1 correlates better with MRI-monitored delivery than does AAV2. It seems likely that the difference in distribution may be due to differences in tissue specificity of the two serotypes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095069      PMCID: PMC2730220          DOI: 10.1016/j.neuroimage.2008.11.012

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  45 in total

1.  Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion.

Authors:  Russell R Lonser; Stuart Walbridge; Kayhan Garmestani; John A Butman; Hugh A Walters; Alexander O Vortmeyer; Paul F Morrison; Martin W Brechbiel; Edward H Oldfield
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

2.  Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain.

Authors:  J B Nguyen; R Sanchez-Pernaute; J Cunningham; K S Bankiewicz
Journal:  Neuroreport       Date:  2001-07-03       Impact factor: 1.837

Review 3.  Gene therapeutic strategies for neurodegenerative diseases.

Authors:  V Baekelandt; B De Strooper; B Nuttin; Z Debyser
Journal:  Curr Opin Mol Ther       Date:  2000-10

4.  Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.

Authors:  K S Bankiewicz; J L Eberling; M Kohutnicka; W Jagust; P Pivirotto; J Bringas; J Cunningham; T F Budinger; J Harvey-White
Journal:  Exp Neurol       Date:  2000-07       Impact factor: 5.330

5.  Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.

Authors:  R Sánchez-Pernaute; J Harvey-White; J Cunningham; K S Bankiewicz
Journal:  Mol Ther       Date:  2001-10       Impact factor: 11.454

6.  Insect cells as a factory to produce adeno-associated virus type 2 vectors.

Authors:  Masashi Urabe; Chuantian Ding; Robert M Kotin
Journal:  Hum Gene Ther       Date:  2002-11-01       Impact factor: 5.695

Review 7.  Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector.

Authors:  J Fraser Wright; Guang Qu; Chunlin Tang; Jurg M Sommer
Journal:  Curr Opin Drug Discov Devel       Date:  2003-03

8.  Adeno-associated virus vector-mediated transduction in the cat brain.

Authors:  Charles H Vite; Marco A Passini; Mark E Haskins; John H Wolfe
Journal:  Gene Ther       Date:  2003-10       Impact factor: 5.250

Review 9.  From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.

Authors:  D Grimm; M A Kay
Journal:  Curr Gene Ther       Date:  2003-08       Impact factor: 4.391

10.  Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery.

Authors:  Christoph Mamot; John B Nguyen; Micheal Pourdehnad; Piotr Hadaczek; Ryuta Saito; John R Bringas; Daryl C Drummond; Keelung Hong; Dmitri B Kirpotin; Tracy McKnight; Mitchel S Berger; John W Park; Krys S Bankiewicz
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

View more
  52 in total

1.  Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC.

Authors:  Piotr Hadaczek; Jamie L Eberling; Philip Pivirotto; John Bringas; John Forsayeth; Krystof S Bankiewicz
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

2.  Analysis of a simulation algorithm for direct brain drug delivery.

Authors:  Kathryn Hammond Rosenbluth; Jan Felix Eschermann; Gabriele Mittermeyer; Rowena Thomson; Stephan Mittermeyer; Krystof S Bankiewicz
Journal:  Neuroimage       Date:  2011-09-14       Impact factor: 6.556

3.  AAV provides an alternative for gene therapy of the peripheral sensory nervous system.

Authors:  Andreas S Beutler
Journal:  Mol Ther       Date:  2010-04       Impact factor: 11.454

Review 4.  Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.

Authors:  Rachel J Sizemore; Sonja Seeger-Armbruster; Stephanie M Hughes; Louise C Parr-Brownlie
Journal:  J Neurophysiol       Date:  2016-02-17       Impact factor: 2.714

5.  Human/nonhuman primate AC-PC ratio--considerations for translational brain measurements.

Authors:  Massimo S Fiandaca; Ernesto Aguilar Salegio; Dali Yin; R Mark Richardson; Francisco E Valles; Paul S Larson; Philip A Starr; Russell R Lonser; Krystof S Bankiewicz
Journal:  J Neurosci Methods       Date:  2010-12-24       Impact factor: 2.390

Review 6.  Gene therapy for misfolding protein diseases of the central nervous system.

Authors:  Waldy San Sebastian; Lluis Samaranch; Adrian P Kells; John Forsayeth; Krystof S Bankiewicz
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

7.  Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum.

Authors:  Waldy San Sebastian; R Mark Richardson; Adrian P Kells; Clementine Lamarre; John Bringas; Philip Pivirotto; Ernesto A Salegio; Stephen J Dearmond; John Forsayeth; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

8.  Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease.

Authors:  Kelly L Sudol; Michael A Mastrangelo; Wade C Narrow; Maria E Frazer; Yona R Levites; Todd E Golde; Howard J Federoff; William J Bowers
Journal:  Mol Ther       Date:  2009-07-28       Impact factor: 11.454

Review 9.  Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.

Authors:  Seung T Lim; Mikko Airavaara; Brandon K Harvey
Journal:  Pharmacol Res       Date:  2009-10-17       Impact factor: 7.658

10.  Novel platform for MRI-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain.

Authors:  R Mark Richardson; Adrian P Kells; Alastair J Martin; Paul S Larson; Philip A Starr; Peter G Piferi; Geoffrey Bates; Lisa Tansey; Kathryn H Rosenbluth; John R Bringas; Mitchel S Berger; Krystof S Bankiewicz
Journal:  Stereotact Funct Neurosurg       Date:  2011-04-14       Impact factor: 1.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.